Artivion price target lowered to $32 from $34 at Needham
https://www.tipranks.com/news/the-fly/jpmorgan-says-lilly-data-highly-favorable-for-structure-therapeutics

In This Article:

Needham lowered the firm’s price target on Artivion (AORT) to $32 from $34 and keeps a Buy rating on the shares after its Q4 results. The company’s constant currency revenue growth slowed to 3.5% from 9.5% in Q3 as the previously disclosed cybersecurity issue disrupted sales while its gross margin was down 200 bps, the analyst tells investors in a research note.

Discover the Best Stocks and Maximize Your Portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on AORT: